iBIO https://ibio.org To promote, connect and engage the life sciences community Mon, 16 Sep 2019 11:01:47 +0000 en-US hourly 1 September Federal Grant Opportunity Report https://ibio.org/september-federal-grant-opportunity-report-2/ https://ibio.org/september-federal-grant-opportunity-report-2/#respond Mon, 16 Sep 2019 11:01:47 +0000 https://ibio.org/?p=4277 iBIO has partnered with G2G Consulting to identify SBIR/STTR and other Government Non-Dilutive Grant opportunities for iBIO Members. Our goal is to increase funding opportunities in Illinois and the utilization of federal grants to support research and small company creation.

Every month we will provide a Government Bioscience Grants Report. This month’s report is published and available for iBIO members to access through G2G’s website:

Password: G2GBio17 (case sensitive)

Don’t Miss: G2G’s Annual Post-MHSRS Conference Webinar for Bioscience & Tech Companies on Thursday, September 26 from 11am-12pm (EDT). Click here to register. Once you RSVP, you’ll receive the link to participate in the webinar.

Highlights:

  1. DoD Combat Readiness BAA (p. 2, grant #4 – when click link, go to “Related Documents Tab” to access full announcement) – focus areas include:
  • Scalable wound care solutions – prevent bleeding, infection, and acute pain; delivery of therapeutics, including non-opioid solutions for pain; and promotion of healing
  • Decision-support solutions – e.g. algorithms, artificial intelligence, deep learning, and/or telemedicine, for triage and management of severely injured Warfighters, to include management and monitoring of: Hemorrhage and resuscitation (i.e., airway management, control of bleeding, sedation, etc.); Acute pain; Multi-casualty events when delayed evacuation exceeds available capability and/or capacity, in order to extend provider capabilities
  • Solutions that address hemorrhage control, including: Non-compressible torso hemorrhage; Alternatives to optimize logistics and administration of blood products to the Warfighter
  • Wearable sensors with broader multiple capabilities to identify and monitor medical management of injuries, to include: Environmental exposures; Onset of infection, including sepsis; Physiological status (heart rate, blood pressure, respiration), stress monitoring tools; Neurological injury; Point-of-care imaging
  1. Patient-Centered Outcomes (pp. 20-21, grants #54-57) – areas of interest include: addressing disparities; assessment of prevention, diagnosis, and treatment options; communication and dissemination research, and improving health systems.
  2. Deadlines for certain CDMRP and USAMRRA funding applications have been adjusted because Hurricane Dorian has prevented some applicants from submitting. Applicants should contact the eBRAP Helpdesk Help@eBRAP.org

September GBG Topic Areas:
Addiction/Substance Abuse (2)
Alzheimer’s Disease (1)
Broad Agency Announcements (15)
Cancer (12)
Cellular Biology (1)
Cybersecurity (1)
Diabetes (2)
Disability and Rehabilitation (1)
Genetics (2)
Global Health Security (1)
Heart, Lung, and Blood (7)
Immunology (2)
Infectious Disease (6)
Kidney (1)
Medically Underserved Populations (1)
Neuroscience (2)
Oral, Dental, Craniofacial Research (1)
Pain Management (1)
Patient-Centered Outcomes (4)
Regenerative Medicine (1)
Rural Health (1)
Traumatic Brain Injury (1)
Other (6)

]]>
https://ibio.org/september-federal-grant-opportunity-report-2/feed/ 0
Top 5 Reasons to Attend the 2019 iCON Awards https://ibio.org/top-5-reasons-to-attend-the-2019-icon-awards/ https://ibio.org/top-5-reasons-to-attend-the-2019-icon-awards/#respond Fri, 13 Sep 2019 12:49:30 +0000 https://ibio.org/?p=4274 The 2019 iCON Awards will be held on September 26th at the Chicago Botanic Garden. With busy schedules and a calendar of other programs to attend, here at the top 5 reasons you shouldn’t miss the 2019 iCON Awards.

 

1) 2019 iCON Honorees

 

The iCON awards recognize the accomplishments of outstanding Illinois life sciences community members in the entrepreneurial, research and education fields. The iCON Awards reception is a great opportunity to celebrate our community through our award winners accomplishments.

This year we will be honoring:

iCON Entrepreneurial Award – Paul Edick, Chairman and CEO,  Xeris Pharmaceuticals
Mr. Edick is Chairman and Chief Executive Office of Xeris Pharmaceuticals, a public specialty pharmaceutical company leveraging novel formulation technology platforms to develop and commercialize ready-to-use, liquid-stable injectables. Prior to Xeris, Mr. Edick was the Chief Executive Officer of Durata Therapeutics which was acquired by Actavis plc, now Allergan plc. Prior to Durata, Mr. Edick was Chief Executive Officer of a number of pharmaceutical companies including Ganic Pharmaceuticals and MedPointe Healthcare, Inc.

iCON Innovator Award –  Dr. Martin D. Burke, Department of Chemistry, University of Illinois Urbana-Champaign and Associate Dean for Research, Carle Illinois College of Medicine
Dr. Burke is a Professor in the Department of Chemistry at UIUC and Associate Dean for Research at the Carle Illinois College of Medicine. Marty’s group has pioneered the field of molecular prosthetics and the development of an automated Lego-like platform for democratizing small molecule synthesis. Marty is also a Founder of four biotechnology companies: REVOLUTION Medicines, Ambys Medicines, Sfunga Therapeutics, and cystetic Medicines.

iCON Knowledge Builder Award – Rebecca Voight, Cooke Magnet Elementary School, Waukegan, IL
Rebecca Voight is a teacher at the Andrew Magnet Elementary School in Waukegan Illinois where Ms Voight is a member of the Instructional Leadership Team and has led the school’s engagement with the STEMgirls Camp for the past three years. Rebecca Voight has a Masters of Education in Curriculum from Lesly University in Cambridge Massachusetts and a B.A. in Elementary Education from Northern Illinois University.

 

2) Support the STEMgirls and StellarGirls Programs

 

The iCON Awards also provides essential funding that supports iBIO’s StellarGirls after school programs and STEMgirls summer camps for girls grades 3-8 in underserved Illinois communities. iBIO’s STEM programs are focused on diversifying the STEM pipeline and target girls at a critical time in the development of their interest in STEM and STEM Careers. To date over 2,700 girls have participated in our programming, our earliest program participants have now graduated high school and are continuing their STEM exploration in college.

At $500/ camper, the cost of the STEMgirls Camp is subsidized by our amazing annual sponsors, Astellas, Abbott, Horizon Therapeutics, and by the proceeds of the iCON Awards. Because of the support of these organizations and the community members we are able to offer camp registration in underserved communities for only $35. But we need your help to continue to support this program so we can expand into new communities. Funds raised at the iCON awards supports the mission of the iBIO Institute, a 501(c)3 Public Charity.

 

3) Networking

 

The iCON Awards is iBIO’s premier networking event, the evening brings together some of Illinois’ top life sciences professionals and innovators from  Abbvie, Astellas, Aptinyx, AveXis, Exicure, Horizon Therapetuics, Lundbeck and Xeris.

The iCON Reception is designed to optimize community networking by replacing banquet style seating and sponsored tables for food stations and open lounge and community seating.

Don’t miss this opportunity to meet with community leaders.

 

4) The Chicago Botanic Garden

 

For the second year, the iCON Awards reception will be held in the beautiful Chicago Botanic Garden. The Chicago Botanic Garden opened more than 40 years ago as a beautiful place to visit, and it has matured into one of the world’s great living museums and conservation science centers. Every year, more than one million people visit the Garden’s 27 gardens and four natural areas, uniquely situated on 385 acres on and around nine islands, with six miles of lake shoreline.

iCON Award attendees will have private access to the Chicago Botanic Gardens.

 

5) Raffle Prizes

 

The iCON Awards will have some amazing raffle prizes donated by iBIO Board members and by leading institutions in Chicagoland to support the programming of our StellarGirls and STEMgirls Camps.

  • Chicago Bull Package: 4 Seats in Section 101, Row 6, Parking Lot Pass, Signed Phil Jackson Sweater.
  • Chicago Blackhawks Package: 2 Seats on the glass in Section 111, Row 1. Parking Pass, and access to the Ketel One Club
  • Fred Astaire Dance Classes: 5 Private Lessons, 1 Group Lesson and a Friday Night Dance Party
  • And many more….

iCON attendees will have the opportunity to win these and other great raffle items.

We promise a wonderful and memorable evening at the beautiful Chicago Botanic Garden featuring networking receptions, cocktail hour, multiple dinner stations, award ceremony and raffle items. We look forward to seeing you on September 26th. 

REGISTER NOW

]]>
https://ibio.org/top-5-reasons-to-attend-the-2019-icon-awards/feed/ 0
Governor Pritzker Signs Legislation to Regulate Pharmacy Benefit Managers https://ibio.org/governor-pritzker-signs-legislation-to-regulate-pharmacy-benefit-managers/ https://ibio.org/governor-pritzker-signs-legislation-to-regulate-pharmacy-benefit-managers/#respond Mon, 02 Sep 2019 12:36:07 +0000 https://ibio.org/?p=4260 Governor J.B. Pritzker signed HB 465 regulating Pharmacy Benefit Managers (PBMs), which are businesses that negotiate prices between drug manufacturers and pharmacies on behalf of insurance companies.

Falling under the Illinois Department of Insurance, the new PBM regulations take several steps to increase access to health care and protect patients:

  • Requires insurers to apply third-party payments, discounts, vouchers and co-pay cards to a deductible, the co-pay or out-of-pocket maximum associated with health insurance
  • Prevents gag clauses which limit pharmacists from advising patients when lower-cost alternatives may be available or when paying cash is cheaper than using insurance
  • Protects consumers entering the emergency room from being denied coverage, even if their ailment turns out to be a non-emergency
  • Provides more transparency in the pricing and reimbursement models PBM utilize by requiring HFS to approval contracts that impact Medicaid

Ben Calcaterra with the Illinois Pharmacists Association says the bill will help keep independent pharmacies open as well. “The PBMs right now are able to set prices well below what pharmacies are able to buy their drugs for and this will give some safeguards so pharmacies will stop closing their doors across the state,” Calcaterra said.

HB 465 was introduced by House Majority Leader Greg Harris (D-13th) House Majority Leader Greg Harris (D-13th) and Senator Andy Manar (D-48th)

 

]]>
https://ibio.org/governor-pritzker-signs-legislation-to-regulate-pharmacy-benefit-managers/feed/ 0
Governor Pritzker Signs Legislation Strengthening Illinois Support for Alzheimer’s Awareness, Research and Care https://ibio.org/governor-pritzker-signs-legislation-strengthening-illinois-support-for-alzheimers-awareness-research-and-care/ https://ibio.org/governor-pritzker-signs-legislation-strengthening-illinois-support-for-alzheimers-awareness-research-and-care/#respond Wed, 28 Aug 2019 12:07:15 +0000 https://ibio.org/?p=4257 On August 26th Governor Pritzker signed SB 1726 which expanded Illinois Alzheimer’s Disease Advisory Committee and the Alzheimer’s Disease Research, Care and Support Fund.

The bill also creates the full-time position of Dementia Coordinator within the Department of Public Health, who is responsible only for activities associated with and relevant to the successful implementation of the State of Illinois Alzheimer’s Disease State Plan.

In 2018 there are an estimated 220,000 persons with Alzheimer’s disease living in Illinois. This figure is projected to reach 240,000 in 2025, a 14 percent increase. If all of the persons with Alzheimer’s disease in Illinois lived in one city, it would be the state’s second largest city.

The growing health and financial impact of Alzheimer’s disease on patients, caregivers, and our healthcare system makes the need for new treatments more pressing. Currently there are 74 clinical-stage programs with disease-modifying potential in Alzheimer’s disease. The drug candidates in these programs are attempting to stop, prevent, or slow the progression of Alzheimer’s disease using 10 different strategies involving 30 distinct molecular targets. Small biotech companies account for more than three-fourths of these clinical programs. 

Read more about the state of innovation for therapeutics in Alzheimer’s disease: The State of Innovation in Highly Prevalent Chronic Diseases Volume IV: Alzheimer’s Disease Therapeutics.

Thank you to Senator Suzy Glowiak HIlton (D – 24th) and Rep. Natalie Manley (D – 98th) for your leadership on this bill.

]]>
https://ibio.org/governor-pritzker-signs-legislation-strengthening-illinois-support-for-alzheimers-awareness-research-and-care/feed/ 0
Announcing the 2019 iCON Honorees https://ibio.org/announcing-the-2019-icon-honorees/ https://ibio.org/announcing-the-2019-icon-honorees/#respond Thu, 22 Aug 2019 12:02:51 +0000 https://ibio.org/?p=4234

2019 iCON Awards
September 26, 2019 – Chicago Botanic Garden

iBIO is excited to announce the honorees of the thirteenth annual iCON Awards – the region’s most prestigious honor for the life sciences educations, researcher and civic visionaries.

The iCON Awards celebrate the accomplishments of outstanding innovators and leaders whose work provides the basis for life sciences developments worldwide. Visit iBIO’s websiteto learn more about tickets and sponsorships opportunities available now.

Funds raised at the iCON Awards ceremony further the mission of iBIO’s nationally-recognized EDUCATE charitable programs which orchestrates business leadership in delivery of world-class educational after-school programs and summer STEM camps for girls grades 3-8 in underserved Illinois schools.

Paul Edick, Chairman & CEO, Xeris Pharmaceuticals

Paul Edick, Chairman & CEO, Xeris Pharmaceuticals

2019 iCON Award Winner

Mr. Edick joined Xeris Pharmaceuticals as Chairman and Chief Executive Officer in January 2017. Prior to joining Xeris, Edick was a Founding Partner of 3G Advisors, a consultancy to the pharmaceutical, healthcare and healthcare investor communities. In addition, Mr. Edick served as the Chief Executive Officer of Durata Therapeutics from 2010-2014 and has held the post of CEO at a number of other pharmaceutical companies, including Ganic Pharmaceuticals and MedPointe Healthcare, Inc. Mr. Edick currently serves as the Chairman of the Board of Milestone Pharmaceuticals Inc. Mr. Edick has also previously served on a number of pharmaceutical and healthcare company boards, including Interim Therapeutics, PDL, BioPharma, Neos Therapeutics, NewLink Genetics Inc., Circassia Pharmaceuticals plc, Sucampo Pharmaceuticals, Amerita Inc., and Informed Medical Communications.

Dr. Martin D. Burke, University of Illinois

Dr. Martin D. Burke, University of Illinois

2019 iCON Innovator Award

Dr. Burke’s group has pioneered the field of molecular prosthetics, including the development of an automated Lego-like platform for democratizing small molecule synthesis. Dr. Burke has received a number of honors and awards, including the Nobel Laureate Signature Award for Graduate Education in Chemistry from the American Chemical Society and has garnered praise for excellence in teaching at both the undergraduate and graduate levels. Dr. Burke is also the founder of four biotechnology companies: REVOLUTION Medicines, Ambys Medicines, Sfunga Therapeutics and Cystetic Medicines.

Rebecca Voight, Cooke Magnet Elementary School, IL

Rebecca Voight, Cooke Magnet Elementary School, IL

2019 iCON Knowledge Builder Award

Rebecca Voight is a teacher at the Andrew Magnet Elementary School in Waukegan Illinois where Ms Voight is a member of the Instructional Leadership Team and has led the school’s engagement with the STEMGirls Camp program for the past three years.

Tickets/table registrations and sponsorship opportunities are now available. Funds raised at the iCON Awards ceremony supports the mission of iBIO’s EDUCATE Programs, a 501(c)3 public charity, which orchestrates business leadership in delivery of world-class educational after-school programs and summer STEM camps for girls grades 3-8 in underserved Illinois schools.

THANK YOU FOR YOUR CONTINUED SUPPORT

The iCON Awards Dinner have been supported by our community’s leading organizations.
Click here for sponsorship information. 

]]>
https://ibio.org/announcing-the-2019-icon-honorees/feed/ 0
August Federal Grant Opportunity Report https://ibio.org/august-federal-grant-opportunity-report/ Wed, 14 Aug 2019 12:05:36 +0000 https://ibio.org/?p=4220 iBIO has partnered with G2G Consulting to identify SBIR/STTR and other Government Non-Dilutive Grant opportunities for iBIO Members. Our goal is to increase funding opportunities in Illinois and the utilization of federal grants to support research and small company creation.

Every month we will provide a Government Bioscience Grants Report. This month’s report is published and available for iBIO members to access through G2G’s website:

Password: G2GBio17 (case sensitive)

Highlights:

SBIR/STTR: Note some opportunities for FDA submission, IP strategy, planning for clinical trial, independent replication of key studies, IND-enabling studies, clinical studies, manufacturing costs, regulatory assistance:

  1. NIH/CDC (p. 20, #54) – Contains opportunities to submit a proposal on close to 40 different topics. Some allow for only a Phase I proposal. Others only allow ‘Direct to Phase II’ and there are some ‘Fast Track’ opportunities, which include both Phase I and Phase II. Click on thislink to see full topic list (scroll to pp. 1-3 of the announcement); full descriptions of each topic can be found by scrolling to p. 66 of the announcement. A few topics listed below to give you sense of what’s there:
    1. Tools and technology for visualizing multi-scale data
    2. Software enabling data interpretation from wearable sensors for cancer patients
    3. Adjuvant discovery of vaccines against infectious or immune-mediated diseases
    4. Several cancer related topics
  2. SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (p.21, #55) – aims to facilitate transition of previously funded SBIR and STTR Phase II and Phase IIB projects to the commercialization stage by providing additional support for technical assistance not typically supported through Phase II or Phase IIB grants or contracts.This may include preparation of documents for a FDA submission, development of an intellectual property strategy, and/or planning for a clinical trial.Clinical trials not accepted under this FOA.
  3. SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (p.21, #56) – aims to facilitate the transition of previously or currently funded SBIR and STTR Phase II and Phase IIB projects to the commercialization stage by providing additional support for technical assistance and later stage research and development not typically supported through Phase II or Phase IIB grants or contracts. This may include independent replication of key studies, Investigational New Drug (IND)-enabling studies, clinical studies, manufacturing costs, regulatory assistance, or a combination of services.


August GBG Topic Areas:
Addiction/Substance Abuse (7)
Aging (6)
Alzheimer’s Disease (4)
Broad Agency Announcements (14)
Cancer (10)
Diabetes (1)
Genetics (4)
Hearing (2)
Heart, Lung, and Blood (4)
Infectious Disease (2)
Kidney (4)
Neuroscience (1)
Pain Management (1)
PTSD (1)
SBIR/STTR (4)
Transplant Research (1)
Traumatic Brain Injury (4)
Other (11)

]]>
Governor Pritzker Signs Legislation Supporting Research & Development Investment in Illinois https://ibio.org/governor-pritzker-signs-legislation-supporting-research-development-investment-in-illinois/ Sat, 03 Aug 2019 14:29:40 +0000 https://ibio.org/?p=4209 On Friday, August 2nd, Governor Pritzker signed SB1591, extending Illinois R&D Tax Credit and establishes a new apprenticeship credit for business to invest in Illinois’ workforce.

R&D is critical to the life sciences industry in Illinois, because innovation in the life sciences industry extend lives, improve quality of life and rive value to patients and the healthcare system as a whole.

Illinois life sciences companies are committed to expanding the boundaries of science by discovering, developing, and delivering innovative and needed medications to patients. To that point, in 2017 Illinois based life sciences companies invested over $14 billion in R&D to discover new medicines, therapies and products for patients.

Modernizing and permanently extending Illinois R&D Tax Credit is one of the key pieces of iBIO’s Life Sciences Economic Blueprint for Illinois. Signing SB1591 to extend Illinois R&D Tax Credit is an important step in that direction. iBIO thanks Governor Pritzker for his leadership in signing this bill.

Research and Development in the life sciences help people live longer, healthier lives and positively impact society. The life sciences industry is just getting started, but to ensure future growth of the industry in Illinois we need to invest in our innovative ecosystem.

]]>
A Look Back at The 2019 STEMgirls Camps https://ibio.org/a-look-back-at-the-2019-stem-girls-camps/ Fri, 02 Aug 2019 12:28:22 +0000 https://ibio.org/?p=4193

The 2019 STEMgirls Summer Camps were held June 3-7 at Southwest Illinois College in Red Bud, IL and June 17-21 at Cristo Rey St. Martin College Prep in Waukegan, IL. The camps were made possible through the generous support of Abbott, Astellas Pharma, Horizon Therapeutics, and Lundbeck as well as local community support in Red Bud. This year, 207 3rd-8th grade girls participated in the camps which offered five days of fun, engineering-focused hands-on STEM activities, field trips and networking with local business and industry partners.

Activities centered around environmental science and utilizing science practices of experimentation and engineering design to solve a variety of problems.

Activities included:

  • Learning about natural and artificial succession and the use of controlled burns as process of forest renewal. Girls designed, built and tested a launcher (catapult, trebuchet, or slingshot) to direct their “potassium permanganate ball” to a specific quadrant of our “forest preserve” to start the most effective burn process.
  • Learning about water molecules, pollution, and pH. Girls performed titrations to balance pH and then used their new knowledge of chemistry in an escape room scenario to determine an unknown source of pollution.
  • Learning about the sorters recycling centers use to automate the process of separating recyclables. Girls designed, built and tested a working, multi-step sorting machine with a conveyor belt to separate paper, metal, and glass and plastic recyclables of different sizes.
  • Girls created and used stream tables to understand the landscape changes caused by water flow. They developed and tested the use of barriers to prevent erosion in strategic urban planning.

“I thought this year was the best yet!! Thank you so much for getting the funding to continue the program! It was the one thing the girls didn’t want to miss this summer” -STEMgirls parent

3rd-6th grade girls in Waukegan visited the Lake County Forest Preserve to learn about conservation and the use of macroorganisms as environmental indicators. 7th and 8th grade girls visited Medline Industries in Mundelein, IL where they evaluated the tensile strength of gloves, examined the flammability of a variety of materials, and tested the chemical make-up of metals and plastics. They also participated in an activity to learn about natural selection and selective pressure. Red Bud campers visited a bird sanctuary.

300 parents attended Family Day events on the last day of camp. The girls’ engineering products were on display and families worked together on an additional challenge to create sustainable packaging that effectively protects against impact damage using paper as the only raw material. Waukegan’s camp included a panel discussion for parents and 7th and 8th grade campers on career opportunities and STEM career paths. Inez Korzun, Supervisor Product Development at Abbott joined women from Astellas, Horizon Therapeutics, Wheeling High School, Cristo Rey St. Martin College Prep., and Lewis University for a panel discussion on preparing girls to succeed in STEM.

In Waukegan alone, a total of 99 volunteers gave of their time and talent by leading activities and networking with campers throughout the week; 40 volunteers from Abbott, 22 from Astellas, 12 from Medline, 9 from AbbVie, and 8 from Dell/EMC and 7 from Horizon.

Campers completed pre- and post-surveys to determine camp’s impact on girls’ impressions of STEM and STEM careers. Both camps successfully increased girls’ posiFve feelings for STEM activities, increased their familiarity with STEM careers, and had broad strong support from families. Further students from both camps increased their interest in pursuing a STEM career after they leave school. Strikingly, 68% of Waukegan campers said a STEM career would be interesting and 55% said they would like to be a scientist when they leave school – gains of 38 and 31 percentage points respectively from pre- to post-survey. 70% of girls said “I think I have good science skills” – a gain of 26 percentage points from pre- to post-test and 73% said “I could take a model that is already built and improve the design,” a gain of 21 percentage points. Campers also increased their familiarity with all ten STEM careers discussed during camp by an average of 30 percentage points.

More than 94% of parents surveyed strongly agreed that the program “made STEM seem fun for their daughter(s)” and more than 73% strongly agreed that “the program will have a lasting positive impact on their daughter(s) after the summer is over.” In previous years, it has been noted that the girls initially confuse engineers with men who work on car engines and maintain that thought on the post- survey. This year 90% of the girls in Red Bud correctly identified an engineer and that they operate within an inquiry-based setting (i.e., they solve novel problems).

Quotes from parent surveys:

“My daughter comes home excited everyday about everything she does. She looks forward to it each year.”

“My oldest loves this program she has been coming every summer since she was in 3rd grade. My youngest got to come for the first and loved it, she wanted to know if she could go next week!”

“My daughter really enjoyed and we appreciate that a camp has been made to specifically encourage young girls to get involved in the sciences. We really hope you have the camp again next year!”

“I am so happy to see a program that encourages girls to go into STEM careers. As a woman engineer myself, I love seeing girls get excited about math, science and especially engineering. I wish more of these opportunities had been available when I was her age.”

“My daughter attended for the first but loved it all week! She couldn’t stop talking about all they did and we will definitely do it again so hopefully it will continue year after year. Great work from all the teachers and assistants!”

“I would rather see an increase in price than to see the program dropped. This is an awesome opportunity for these girls.”

“I thought this year was the best yet!! Thank you so much for getting the funding to continue the program! It was the one thing the girls didn’t want to miss this summer.”

The STEMgirls camps would not be possible without the support of our sponsors, Astellas, Abbott, Horizon Therapeutics and Lundbeck.

Please consider helping us continue to grow and expand our STEMgirls camps by attending the 2019 iCON Awards Dinner, or make a direct donation to the Camps below.

]]>
An Exclusive 10% off The MedTech Conference for iBIO Members https://ibio.org/an-exclusive-10-off-the-medtech-conference-for-ibio-members/ Tue, 23 Jul 2019 16:04:51 +0000 https://ibio.org/?p=3997 Make plans today to attend The MedTech Conference this September 23–25, 2019, in Boston, MA.

Over 3,000 top medtech executives and decision makers from more than 35 countries will gather in the medtech powerhouse of Massachusetts this year to learn about the newest developments in medical technology. The MedTech Conferencefeatures cutting-edge educational programming, a dynamic Exhibit Hall, plenary sessions and networking opportunities. This year, The MedTech Conference Exhibit Hall will open on Monday, Sept. 23, giving you an extra day to network, visit 130+ exhibitors and take in presentations at any of the six stages!

We’ve partnered with The MedTech Conference to offer our members an extra 10% off early bird rates with code SPO19.

Early bird pricing ends July 26. Don’t miss out on this opportunity to save. Register now at themedtechconference.com.

I look forward to seeing you in Boston!

]]>
Governor Pritzker Signs Legislation Increasing Awareness and Education About Parkinson’s Disease https://ibio.org/governor-pritzker-signs-legislation-increasing-awareness-and-education-about-parkinsons-disease/ Mon, 22 Jul 2019 12:11:54 +0000 https://ibio.org/?p=3992 On Friday, July 19, Governor Pritzker signed HB 3247, creating the Parkinson’s Disease Public Awareness and Education Act.

The act provides that the Director of Public Health develop a Parkinson’s disease public awareness and education program focusing on the value of early detection and possible treatments.

iBIO applauds the leadership of Governor Pritzker, Representative Latoya Greenwood and Senator Christopher Belt for this important legislation.

]]>